Home / Duloxetine / Canada
CA ATC N06AX21 · updated 2 Nov 2026
Duloxetine shortage in Canada
Is there a Duloxetine shortage in Canada?
Yes. As of 2 Nov 2026, 5 Duloxetine products are reported short in Canada, the first since 24 Jun 2026. The company estimate for the return is 20 Nov 2026. Main reason: manufacturing problem.
Also short in Germany, France, Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-DULOXETINE (UD30) | TEVA CANADA LIMITED | 24 Jun 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DULOXETINE (500 BTL) | APOTEX INC | 28 Jul 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DULOXETINE (30 BLS) | APOTEX INC | 19 Oct 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DULOXETINE (500 BTL) | APOTEX INC | 27 Oct 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DULOXETINE (100) discontinuation | SANIS HEALTH INC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.